Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,775 | 4,491 | 6,148 | 8,356 | 727 |
| Marketable Securities | 486 | 535 | 969 | 939 | 1,860 |
| Receivables | 77 | 819 | 1,128 | 1,189 | 1,149 |
| Inventories | N/A | 153 | 108 | 108 | 185 |
| TOTAL | $3,160 | $6,772 | $9,291 | $11,680 | $4,819 |
| Non-Current Assets | |||||
| PPE Net | 464 | 1,090 | 981 | 1,009 | 1,004 |
| Intangibles | 3,207 | 4,572 | 4,677 | 4,782 | 4,887 |
| Other Non-Current Assets | 4,259 | 1,229 | 851 | 1,025 | 1,101 |
| TOTAL | $7,930 | $6,891 | $6,509 | $6,816 | $6,992 |
| Total Assets | $11,090 | $13,663 | $15,800 | $18,496 | $11,811 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,341 | N/A | N/A | 251 | 338 |
| Accounts payable and accrued liabilities | 1,728 | 1,434 | 1,194 | 1,655 | 1,780 |
| Accrued Expenses | 311 | 783 | 832 | 572 | 311 |
| TOTAL | $10,553 | $11,758 | $3,538 | $3,658 | $3,613 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,603 | 204 | 247 | 355 | 282 |
| Deferred Revenues | 173 | 1,173 | 1,177 | 1,180 | 1,184 |
| Other Non-Current Liabilities | 1,595 | 5,500 | 13,530 | 13,530 | 13,741 |
| TOTAL | $7,198 | $5,704 | $13,777 | $13,885 | $14,023 |
| Total Liabilities | $17,751 | $17,462 | $17,315 | $17,543 | $17,636 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 2 | 2 | 2 | 2 |
| Common Shares | 155 | 155 | 155 | 154 | 134 |
| Retained earnings | -64,465 | -61,562 | -59,134 | -56,581 | -54,227 |
| Other shareholders' equity | -1,361 | -1,395 | -1,420 | -1,426 | -1,329 |
| TOTAL | $-6,661 | $-3,799 | $-1,515 | $953 | $-5,825 |
| Total Liabilities And Equity | $11,090 | $13,663 | $15,800 | $18,496 | $11,811 |